19 June 2013
Keywords: tanox, osteoporosis, deal, wyeth, usa-based, signed, agreements
Article | 17 November 2003
USA-based Tanox has signed agreements with Wyeth Pharmaceuticals todevelop new classes of drugs for the treatment of osteoporosis.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2003
24 November 2003
3 November 2003
© 2013 thepharmaletter.com